109 related articles for article (PubMed ID: 9310083)
21. The relationship between plasma viscosity and cholesterol in postmenopausal women on hormone replacement therapy.
Konukoglu D; Serin O; Ercan M
Clin Hemorheol Microcirc; 2000; 22(3):223-8. PubMed ID: 10976716
[TBL] [Abstract][Full Text] [Related]
22. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
Meilahn EN; Cauley JA; Tracy RP; Macy EO; Gutai JP; Kuller LH
Am J Epidemiol; 1996 Jan; 143(2):159-66. PubMed ID: 8546117
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.
Barinas-Mitchell E; Cushman M; Meilahn EN; Tracy RP; Kuller LH
Am J Epidemiol; 2001 Jun; 153(11):1094-101. PubMed ID: 11390329
[TBL] [Abstract][Full Text] [Related]
24. Relationship of physical fitness, hormone replacement therapy, and hemostatic risk factors in postmenopausal women.
Szymanski LM; Kessler CM; Fernhall B
J Appl Physiol (1985); 2005 Apr; 98(4):1341-8. PubMed ID: 15591298
[TBL] [Abstract][Full Text] [Related]
25. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease.
Redberg RF; Nishino M; McElhinney DB; Dae MW; Botvinick EH
Am Heart J; 2000 Apr; 139(4):739-44. PubMed ID: 10740161
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women.
Scuteri A; Bos AJ; Brant LJ; Talbot L; Lakatta EG; Fleg JL
Ann Intern Med; 2001 Aug; 135(4):229-38. PubMed ID: 11511137
[TBL] [Abstract][Full Text] [Related]
27. [Effect of hormone replacement therapy on homocysteine and echocardiography in postmenopausal women].
Hui Y; Wu Y; Xiao L; Tang Z; Wu Y; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Oct; 37(10):598-600. PubMed ID: 12487933
[TBL] [Abstract][Full Text] [Related]
28. Physical activity, body fat, and serum C-reactive protein in postmenopausal women with and without hormone replacement.
Manns PJ; Williams DP; Snow CM; Wander RC
Am J Hum Biol; 2003; 15(1):91-100. PubMed ID: 12552583
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III).
Crespo CJ; Smit E; Snelling A; Sempos CT; Andersen RE;
Diabetes Care; 2002 Oct; 25(10):1675-80. PubMed ID: 12351460
[TBL] [Abstract][Full Text] [Related]
30. Influence of habitual physical activity on body composition, fat distribution and metabolic variables in early postmenopausal women receiving hormonal therapy.
Lara S; Casanova G; Spritzer PM
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):52-6. PubMed ID: 20189290
[TBL] [Abstract][Full Text] [Related]
31. [Influence of estrogen replacement therapy on atherogenic profile in postmenopausal women].
Alfonso Cano C; Vez García MD; García Urruticoechea P; Tornel Osorio PL; Canteras Jordana M; Abellán Alemán J
An Med Interna; 2003 Feb; 20(2):70-4. PubMed ID: 12703158
[TBL] [Abstract][Full Text] [Related]
32. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
Sieminska L; Wojciechowska C; Niedziolka D; Marek B; Kos-Kudla B; Kajdaniuk D; Nowak M
Metabolism; 2005 Dec; 54(12):1610-4. PubMed ID: 16311093
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress levels are reduced in postmenopausal women with exercise training regardless of hormone replacement therapy status.
Attipoe S; Park JY; Fenty N; Phares D; Brown M
J Women Aging; 2008; 20(1-2):31-45. PubMed ID: 18581699
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
35. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular hemodynamics with increasing exercise intensities in postmenopausal women.
McCole SD; Brown MD; Moore GE; Zmuda JM; Cwynar JD; Hagberg JM
J Appl Physiol (1985); 1999 Dec; 87(6):2334-40. PubMed ID: 10601186
[TBL] [Abstract][Full Text] [Related]
37. Systemic hemodynamic determinants of blood pressure in women: age, physical activity, and hormone replacement.
Hunt BE; Davy KP; Jones PP; DeSouza CA; Van Pelt RE; Tanaka H; Seals DR
Am J Physiol; 1997 Aug; 273(2 Pt 2):H777-85. PubMed ID: 9277495
[TBL] [Abstract][Full Text] [Related]
38. Plasma fibrinogen: its relationship with oral contraception, the menopause, and hormone replacement therapy.
Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
Clin Biochem; 1992 Oct; 25(5):403-5. PubMed ID: 1490307
[TBL] [Abstract][Full Text] [Related]
39. HRT provides no additional beneficial effect on sarcopenia in physically active postmenopausal women: a cross-sectional, observational study.
Aubertin-Leheudre M; Audet M; Goulet ED; Dionne IJ
Maturitas; 2005 Jun; 51(2):140-5. PubMed ID: 15917154
[TBL] [Abstract][Full Text] [Related]
40. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
Munoz J; Derstine A; Gower BA
Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
